Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 Infection

This publication has 32 references indexed in Scilit:

• Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy
  Clinical Immunology, 2001
• The Prognostic Significance in HIV Infection of Immune Activation Represented by Cell Surface Antigen and Plasma Activation Marker Changes
  Clinical Immunology, 1999
• Serum HIV–1 RNA Levels Compared to Soluble Markers of Immune Activation to Predict Disease Progression in HIV–1–Infected Individuals
  International Archives of Allergy and Immunology, 1998
• Relationship of Plasma HIV-RNA Levels and Levels of TNF-α and Immune Activation Products in HIV Infection
  Clinical Immunology and Immunopathology, 1997
• Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects
  Science, 1996
• Multiple Imputation After 18+ Years
  Journal of the American Statistical Association, 1996
• Prognostic Value of Combined Response Markers Among Human Immunodeficiency Virus-Infected Persons: Possible Aid in the Decision to Change Zidovudine Monotherapy
  Clinical Infectious Diseases, 1995
• Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.
  The Journal of Experimental Medicine, 1990
• The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1
  New England Journal of Medicine, 1990
• Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.
  The Journal of Experimental Medicine, 1984